Sasha discusses the complexities of mRNA manufacturing, emphasizing the need for extensive studies on both the mRNA and lipid nanoparticles. She highlights that the research conducted was insufficient, relying on outdated studies from unrelated mRNA projects rather than focusing specifically on the COVID vaccine. This raises critical questions about the safety and efficacy of the current mRNA products.
